Obesity Research Today is a free monthly online journal that collates and summarizes the latest research about Obesity, including details on health, diet, prevention, exercise.

Childhood obesity prevention programs: how do they affect eating pathology and other psychological measures?

Carter FA, Bulik CM

Department of Psychological Medicine, Christchurch School of Medicine, Otago University, PO Box 4345, Christchurch, New Zealand. frances.carter@otago.ac.nz

OBJECTIVES: First, to examine how well eating pathology and other psychological measures have been assessed by childhood obesity prevention programs. Second, to evaluate the impact of these programs on eating pathology and other psychological measures. METHODS: Studies were identified in a Cochrane Collaboration review assessing the effectiveness of interventions designed to prevent obesity in childhood through the use of diet, physical activity, and/or lifestyle and social support (Summerbell C et al., Cochrane Database Syst Rev 2005:CD001871). Studies were required to be either randomized controlled trials or controlled clinical trials with a minimum duration of 12 weeks. These studies were systematically examined. RESULTS: Twenty-two studies were identified by the Cochrane Collaboration Review. No studies compared the rates of eating disorders or other psychiatric disorders across intervention and control groups. Symptoms of eating disorders, global measures of well being and functioning, and psychosocial variables of particular relevance to obesity such as attitudes related to food and physical activity were assessed by a minority of studies, and some measures were problematic. With the exception of one measure on one study, findings suggest that participants receiving an active intervention either did not differ significantly from the control group, or they experienced significant benefits on those psychological measures that were assessed. CONCLUSIONS: The existing evidence does not support the view that childhood obesity prevention programs are associated with unintended psychological harm. However, because these variables have been so poorly assessed, conclusions about the possible iatrogenic effects of these programs are premature.

Published 14 April 2008 in Psychosom Med, 70(3): 363-71.
Full-text of this article is available online (may require subscription).

Articles on Obesity published 14 April 2008:

Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.   Psychosom Med, 70(3): 288-97.

OBJECTIVE: This study evaluated associations between body mass index (BMI) and psychiatric disorders. METHODS: Data from 41,654 respondents in the National Epidemiologic Survey on Alcohol and Related Conditions were analyzed. RESULTS: After controlling for demographics, the continuous variable of BMI was significantly associated with most mood, anxiety, and personality disorders. When persons were classified into BMI categories of underweight, normal weight, overweight, obese, and extremely ... [Abstract] [Full-text]

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.   Fertil Steril, 89(4): 899-906.

OBJECTIVE: To investigate the combined effect of diet and orlistat, for 24 weeks, on anthropometric features, hormonal parameters, and indices of insulin resistance in obese women with polycystic ovary syndrome (PCOS) and in obese women without the syndrome. DESIGN: Prospective clinical study. SETTING: Department of obstetrics and gynecology in a major university in Greece. PATIENT(S): Eighteen selected women with PCOS were matched for age and body mass index with 14 obese control women. ... [Abstract] [Full-text]

Articles on Obesity published 8 April 2008:

Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study.   Gastroenterology, 134(4): 953-9.

BACKGROUND & AIMS: Obesity is an important correlate of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. We sought to examine the relations between parental obesity and the serum ALT and AST levels among offspring in a community-based sample. METHODS: Participants (n = 1732) of the Framingham Offspring Study (50% women; mean age, 42 years) who had serum ALT and AST measurements and both parents in the original Framingham cohort were studied. Study ... [Abstract] [Full-text]

Articles on Obesity published 4 April 2008:

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.   JAMA, 299(13): 1547-60.

CONTEXT: Abdominal obesity is associated with metabolic abnormalities and increased risk of atherosclerotic cardiovascular disease. However, no obesity management strategy has demonstrated the ability to slow progression of coronary disease. OBJECTIVE: To determine whether weight loss and metabolic effects of the selective cannabinoid type 1 receptor antagonist rimonabant reduces progression of coronary disease in patients with abdominal obesity and the metabolic syndrome. DESIGN, SETTING, AND ... [Abstract] [Full-text]

Causes of early mortality after laparoscopic adjustable gastric banding.   J Am Coll Surg, 206(4): 664-9.

BACKGROUND: Laparoscopic adjustable gastric banding (LAGB) is 1 of the most used surgical procedures to treat obesity, with > 120,000 bands positioned around the world. LAGB is considered a safe and technically simple procedure, but it has many longterm complications, such as erosion, bleeding that requires reoperations, and sometimes even death of the patient. STUDY DESIGN: This article reviews the deaths after LAGB reported in the literature. Eight hundred eighty articles were reviewed ... [Abstract] [Full-text]

Articles on Obesity published 3 April 2008:

Association between obesity during pregnancy and increased use of health care.   N Engl J Med, 358(14): 1444-53.

BACKGROUND: In the United States, obesity during pregnancy is common and increases obstetrical risks. An estimate of the increase in use of health care services associated with obesity during pregnancy is needed. METHODS: We used electronic data systems of a large U.S. group-practice health maintenance organization to identify 13,442 pregnancies among women 18 years of age or older at the time of conception that resulted in live births or stillbirths. The study period was between January 1, ... [Abstract] [Full-text]

Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice.   Reprod Biol Endocrinol, 6: 10.

BACKGROUND: Women with polycystic ovary syndrome (PCOS) are often treated with insulin-sensitizing agents, e.g. thiazolidinediones (TZD), which have been shown to reduce androgen levels and improved ovulatory function. Acting via peroxisome proliferator-activated receptor (PPAR) gamma, TZD alter the expression of a large variety of genes. Lethal yellow (LY; C57BL/6J Ay/a) mice, possessing a mutation (Ay) in the agouti gene locus, exhibit progressive obesity, reproductive dysfunction, and ... [Abstract] [Full-text]

Articles on Obesity published 2 April 2008:

A policy-based school intervention to prevent overweight and obesity.   Pediatrics, 121(4): e794-802.

BACKGROUND: The prevalence and seriousness of childhood obesity has prompted calls for broad public health solutions that reach beyond clinic settings. Schools are ideal settings for population-based interventions to address obesity. OBJECTIVE: The purpose of this work was to examine the effects of a multicomponent, School Nutrition Policy Initiative on the prevention of overweight (85.0th to 94.9th percentile) and obesity (> 95.0th percentile) among children in grades 4 through 6 over a ... [Abstract] [Full-text]

© 2004-2008 Obesity Research Today. All Rights Reserved.